Subscribe to RSS
Download PDF
DOI: 10.1160/TH09-11-0748
Early-onset ischaemic stroke: Analysis of 58 polymorphisms in 17 genes involved in methionine metabolism
Financial support: This work was supported by grants from Italian Ministry of Health “Ricerca Finalizzata 2005: Non-cardioembolic atherothrombotic stroke”, “Genopolis” government FIRB project (RBLA038RMA_008), Italian Ministry of Health (IRCCS), Ingenius Hypercare European Program and from Fiorgen Foundation, Florence, Italy.
Publication History
Received:
03 November 2009
Accepted after major revision:
16 March 2010
Publication Date:
24 November 2017 (online)
Summary
The hypothesis underlying this study is that variations in genes involved in methionine metabolism may contribute to genetic susceptibility for early-onset ischaemic stroke. We investigated 58 polymorphisms in AHCY, BHMT, BHMT2, CBS, ENOSF1, FOLH1, MTHFD1, MTHFR, MTR, MTRR, NNMT, PON1, PON2, SLC19A1, SHMT1, TCN2, TYMS genes on genomic DNA from 501 young patients who survived ischaemic stroke and 1,211 sex and age comparable controls. Genotype distribution was significantly different between patients and controls for the following SNPs: rs10037045 BHMT, rs682985 BHMT2, rs1051319 CBS, rs202680 FOLH1, rs2274976 MTHFR, rs1979277 SHMT1, rs20721958 TCN2. On multiple logistic regression analysis adjusted for traditional risk factors, rs10037045 BHMT, rs682985 BHMT2, rs1051319 CBS, and rs202680 FOLH1 remained independent risk factors for stroke. After haplotype reconstruction, generalised linear model analyses adjusted for traditional risk factors and using the FDR multiple testing correction showed significant associations between ischaemic stroke and BHMT, CBS, FOLH1, MTR, PON2, TCN2 and TYMS haplotypes. This study identifies significant genetic associations between premature ischaemic stroke and haplotypes in BHMT, CBS, FOLH1, MTR, PON2, TCN2 and TYMS genes involved in methionine metabolism.
-
References
- 1 McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969; 56: 111-128.
- 2 Nygård O, Nordrehaug JE, Refsum H. et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997; 337: 230-236.
- 3 Verhoef P, Hennekens CH, Malinow MR. et al. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. J Am Med Assoc 1992; 268: 877-881.
- 4 Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. Br Med J 2002; 325: 1202-1206.
- 5 The Homocysteine Studies Collaboration Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. J Am Med Assoc 2002; 288: 2015-2022.
- 6 Wald DS, Wald NJ, Morris JK. et al. Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence. Br Med J 2006; 333: 1114-1117.
- 7 Undas A, Brozek J, Szczeklik A. Homocysteine and thrombosis: from basic science to clinical evidence. Thromb Haemost 2005; 94: 907-915.
- 8 Lievers KJ, Kluijtmans LA, Blom HJ. Genetics of hyperhomocysteinaemia in cardiovascular disease. Ann Clin Biochem 2003; 40: 46-59.
- 9 Gellekink H, den Heijer M, Heil SG. et al. Genetic determinants of plasma total homocysteine. Semin Vasc Med 2005; 05: 98-109.
- 10 Sharma P, Senthilkumar RD, Brahmachari V. et al. Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studies. Lipids Health Dis 2006; 05: 1.
- 11 Frosst P, Blom HJ, Milos R. et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-113.
- 12 Weisberg I, Tran P, Christensen B. et al. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 1998; 64: 169-172.
- 13 Perla-Kajan J, Twardowski T, Jakubowski H. Mechanisms of homocysteine toxicity in humans. Amino Acids 2007; 32: 561-572.
- 14 Waterland RA. Assessing the effects of high methionine intake on DNA methylation. J Nutr 2006; 136: 1706S-1710S.
- 15 Rubattu S, Speranza R, Ferrari M. et al. A role of TNF-alpha gene variant on juvenile ischemic stroke: a case-control study. Eur J Neurol 2005; 12: 989-993.
- 16 Frezzato M, Tosetto A, Rodeghiero F. Validated questionnaire for the identification of previous personal or familial venous thromboembolism. Am J Epidemiol 1996; 143: 1257-1265.
- 17 Giusti B, Saracini C, Bolli P. et al. Genetic analysis of 56 polymorphisms in 17 genes involved in methionine metabolism in patients with abdominal aortic aneurysm. J Med Genet 2008; 45: 721-730.
- 18 Giusti B, Sestini I, Saracini C. et al. High-throughput multiplex single-nucleotide polymorphism (SNP) analysis in genes involved in methionine metabolism. Biochem Genet 2008; 46: 406-423.
- 19 Scheet P, Stephens M. A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase. Am J Hum Genet 2006; 78: 629-644.
- 20 Becker T, Cichon S, Jonson E, Knapp M. Multiple testing in the context of haplotype analysis revisited: application to case-control data. Ann Hum Genet 2005; 69: 747-756.
- 21 Becker T, Schumacher J, Cichon S. et al. Haplotype interaction analysis of unlinked regions. Genet Epidemiol 2005; 29: 313-322.
- 22 Bersano A, Ballabio E, Bresolin N, Candelise L. Genetic polymorphisms for the study of multifactorial stroke. Hum Mutat 2008; 29: 776-795.
- 23 Sazci A, Ergul E, Tuncer N. et al. Methylenetetrahydrofolate reductase gene polymorphisms are associated with ischemic and hemorrhagic stroke: Dual effect of MTHFR polymorphisms C677T and A1298C. Brain Res Bull 2006; 11: 45-50.
- 24 Wang X, Qin X, Demirtas H. et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet 2007; 369: 1876-1882.